Post Profile






Is androgen deprivation therapy for prostate cancer associated with dementia?

(The JAMA Network Journals) Androgen deprivation therapy is a mainstay of prostate cancer treatment. ADT has shown survival benefit in some patients but it also has been associated with some adverse health effects and a possible link to neurocognitive dysfunction.
read more

share

Related Posts


Long-Term Androgen Deprivation (LTAD) Therapy Combined with High-Dose Radiation Therapy (HDRT) for Prostate Cancer Improves Biochemical Control and Survival Rates

Health : Newswise Medical News

Prostate cancer patients who receive high-dose radiation therapy (HDRT) followed by a longer period of hormone suppression therapy, or androgen deprivation therapy (ADT), have higher five-year biochemical, disease-free survival (bDF...

Prostate Cancer Treatment Can Raise Dementia Risk

Health : Well

Reducing testosterone levels with androgen deprivation therapy, or A.D.T., more than doubles the risk of dementia.

Medical News Today: Hormone therapy for prostate cancer may raise dementia risk

Health : Medical News Today

Men treated with androgen deprivation therapy - a hormone therapy - for prostate cancer may be more than twice as likely to develop dementia, study finds.

Common Prostate Cancer Treatment Tied to Dementia

Health : Newswise Medical News

Androgen Deprivation Therapy, a common hormone therapy to treat prostate cancer, may double a man's risk of dementia, regardless of his age, Penn Medicine researchers reported.

Common prostate cancer treatment linked to later dementia, Stanford researcher says

Diseases & Conditions / Cancer : EurekAlert: Cancer

(Stanford University Medical Center) A new retrospective study of the health records of prostate cancer patients supports an association between androgen deprivation therapy and future risk of dementia.

Comments


Copyright © 2016 Regator, LLC